Cargando…
Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?
Dengue is one of the most important diseases transmitted by mosquitoes. Dengvaxia®, a vaccine registered in several countries, cannot be administered to non-immune individuals and children younger than 9 years old, due to safety reasons. There are two vaccine candidates in phase 3 efficacy trials, b...
Autores principales: | Valdés, Iris, Lazo, Laura, Hermida, Lisset, Guillén, Gerardo, Gil, Lázaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718459/ https://www.ncbi.nlm.nih.gov/pubmed/31507591 http://dx.doi.org/10.3389/fimmu.2019.01956 |
Ejemplares similares
-
The tetravalent formulation of domain III-capsid proteins recalls memory B- and T-cell responses induced in monkeys by an experimental dengue virus infection
por: Gil, Lázaro, et al.
Publicado: (2017) -
Screening for immune response against Dengue virus in Vietnamese non-human primates: implications for vaccine developers
por: Lazo Vázquez, Laura, et al.
Publicado: (2017) -
Wanted Dead or Alive: A Correlate of Protection Against Dengue Virus
por: Gil, Lázaro, et al.
Publicado: (2019) -
Ebola-GP DNA Prime rAd5-GP Boost: Influence of Prime Frequency and Prime/Boost Time Interval on the Immune Response in Non-human Primates
por: Marcus, Hadar, et al.
Publicado: (2021) -
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System
por: Ciabattini, Annalisa, et al.
Publicado: (2018)